Login

Experience the Drillmore difference| Babak Bemani , Chief Executive Officer at Drillmore 00:10:00

Share On Facebook Share On Twitter

Babak Bemani is a CEO & Founder of Bit Azin and Drillmore Canada

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Monty Copper Mine: Moving Towards Production in Western Australia
00:10:00
Exploring the Surge of Multi-Manager Platforms and Their Impact on Diversification and Risk Management with Insights from Curtis Arledge and Joe Lacovara of Mariner Investment Group
00:10:00
Grateful for Keystone Global Network's Support in My Canadian Visa Process
00:10:00
we are focused on discovering developing and commercializing novel gene and cell therapies and vaccines|Jon Lieber, Chief Financial Officer,Histogenics Corp
00:10:00
From combating food waste to pioneering projects|Archie Thomason,Associate,Milltrust International LLP
00:10:00
Scotiabank CEO Scott Thompson on Strategic Vision and Navigating North American Markets | Scott Thompson, CEO, Scotiabank.
00:10:00
GoldSource Mines: Scalability and Growth Potential of the Eagle Mountain Gold Project in Guyana
00:10:00
Deciphering Private Equity: Insights from Sara Razi, Simpson Thacher & Bartlett LLP |Alden Millard - Partner,Chair of the Executive Committee of Simpson Thacher
00:10:00
Cyber Boot Camp: Building Relationships and Advancing Research in Cybersecurity
00:10:00
Invests in commercial-stage digital health, tech-enabled healthcare services|Becca Shmukler,Principal, Laerdal Million Lives Fund
00:10:00
Decades of Market Wisdom: Tangu Tan's Insights on Malaysia's Economic Landscape | Tan Teng Boo, CEO ,  Capital Dynamics.
00:10:00
Low Lift, High Impact- Changing the Investing Narrative|Lolita Taub,General Partner,Ganas Ventures

© 2026 Nehu